1 Growth Stock with All-Star Potential and 2 We Find Risky
ARLINGTON, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named...
3 of Wall Street’s Favorite Stocks We Find Risky
Privia Health (PRVA): Buy, Sell, or Hold Post Q4 Earnings?
Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale.
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know
Privia Health (NASDAQ:PRVA) Reports Strong Q4 CY2025
All 2025 Operating and Financial Metrics At or Above High End of Guidance Ranges Full-year 2025 Net Income +59.3% from 2024 Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from...
Privia Health (PRVA) Reports Q4: Everything You Need To Know Ahead Of Earnings